nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Nelarabine—Fludarabine—lymphatic system cancer	0.309	0.352	CrCrCtD
Abacavir—Nelarabine—Cytarabine—lymphatic system cancer	0.292	0.332	CrCrCtD
Abacavir—Cladribine—Fludarabine—lymphatic system cancer	0.278	0.316	CrCrCtD
Abacavir—Pneumonia—Vincristine—lymphatic system cancer	0.000383	0.00314	CcSEcCtD
Abacavir—Depression—Vincristine—lymphatic system cancer	0.000379	0.00311	CcSEcCtD
Abacavir—Anorexia—Fludarabine—lymphatic system cancer	0.000379	0.00311	CcSEcCtD
Abacavir—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000375	0.00308	CcSEcCtD
Abacavir—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.000375	0.00308	CcSEcCtD
Abacavir—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000373	0.00306	CcSEcCtD
Abacavir—Myocardial infarction—Vincristine—lymphatic system cancer	0.000373	0.00306	CcSEcCtD
Abacavir—Pneumonia—Mitoxantrone—lymphatic system cancer	0.000373	0.00306	CcSEcCtD
Abacavir—Feeling abnormal—Teniposide—lymphatic system cancer	0.000372	0.00306	CcSEcCtD
Abacavir—Stomatitis—Vincristine—lymphatic system cancer	0.000371	0.00304	CcSEcCtD
Abacavir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00037	0.00303	CcSEcCtD
Abacavir—Chills—Bleomycin—lymphatic system cancer	0.000368	0.00302	CcSEcCtD
Abacavir—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000365	0.003	CcSEcCtD
Abacavir—Renal failure—Mitoxantrone—lymphatic system cancer	0.000364	0.00299	CcSEcCtD
Abacavir—Nausea—Mechlorethamine—lymphatic system cancer	0.000364	0.00299	CcSEcCtD
Abacavir—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000363	0.00298	CcSEcCtD
Abacavir—Alopecia—Bleomycin—lymphatic system cancer	0.000362	0.00297	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000362	0.00297	CcSEcCtD
Abacavir—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000361	0.00297	CcSEcCtD
Abacavir—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00036	0.00296	CcSEcCtD
Abacavir—Urticaria—Teniposide—lymphatic system cancer	0.000359	0.00295	CcSEcCtD
Abacavir—Abdominal pain—Teniposide—lymphatic system cancer	0.000357	0.00293	CcSEcCtD
Abacavir—Body temperature increased—Teniposide—lymphatic system cancer	0.000357	0.00293	CcSEcCtD
Abacavir—Paraesthesia—Fludarabine—lymphatic system cancer	0.000357	0.00293	CcSEcCtD
Abacavir—Dyspnoea—Fludarabine—lymphatic system cancer	0.000354	0.00291	CcSEcCtD
Abacavir—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000352	0.00289	CcSEcCtD
Abacavir—Decreased appetite—Fludarabine—lymphatic system cancer	0.000345	0.00283	CcSEcCtD
Abacavir—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000343	0.00282	CcSEcCtD
Abacavir—Fatigue—Fludarabine—lymphatic system cancer	0.000342	0.00281	CcSEcCtD
Abacavir—Inflammation—Methotrexate—lymphatic system cancer	0.00034	0.00279	CcSEcCtD
Abacavir—Pain—Fludarabine—lymphatic system cancer	0.00034	0.00279	CcSEcCtD
Abacavir—Respiratory failure—Methotrexate—lymphatic system cancer	0.000336	0.00276	CcSEcCtD
Abacavir—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000336	0.00276	CcSEcCtD
Abacavir—Hypersensitivity—Teniposide—lymphatic system cancer	0.000333	0.00273	CcSEcCtD
Abacavir—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000333	0.00273	CcSEcCtD
Abacavir—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000331	0.00272	CcSEcCtD
Abacavir—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00033	0.00271	CcSEcCtD
Abacavir—Anaemia—Bleomycin—lymphatic system cancer	0.00033	0.00271	CcSEcCtD
Abacavir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000327	0.00269	CcSEcCtD
Abacavir—Asthenia—Teniposide—lymphatic system cancer	0.000324	0.00266	CcSEcCtD
Abacavir—Malaise—Bleomycin—lymphatic system cancer	0.000322	0.00264	CcSEcCtD
Abacavir—Pruritus—Teniposide—lymphatic system cancer	0.00032	0.00263	CcSEcCtD
Abacavir—Leukopenia—Bleomycin—lymphatic system cancer	0.000319	0.00262	CcSEcCtD
Abacavir—Alopecia—Carmustine—lymphatic system cancer	0.000316	0.0026	CcSEcCtD
Abacavir—Body temperature increased—Fludarabine—lymphatic system cancer	0.000314	0.00258	CcSEcCtD
Abacavir—Malnutrition—Carmustine—lymphatic system cancer	0.000311	0.00256	CcSEcCtD
Abacavir—Cough—Bleomycin—lymphatic system cancer	0.000311	0.00256	CcSEcCtD
Abacavir—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.00031	0.00254	CcSEcCtD
Abacavir—Diarrhoea—Teniposide—lymphatic system cancer	0.000309	0.00254	CcSEcCtD
Abacavir—Myalgia—Bleomycin—lymphatic system cancer	0.000304	0.00249	CcSEcCtD
Abacavir—Alopecia—Vincristine—lymphatic system cancer	0.000302	0.00248	CcSEcCtD
Abacavir—Discomfort—Bleomycin—lymphatic system cancer	0.0003	0.00246	CcSEcCtD
Abacavir—Chills—Mitoxantrone—lymphatic system cancer	0.000298	0.00245	CcSEcCtD
Abacavir—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000298	0.00245	CcSEcCtD
Abacavir—Alopecia—Mitoxantrone—lymphatic system cancer	0.000294	0.00241	CcSEcCtD
Abacavir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000293	0.0024	CcSEcCtD
Abacavir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000291	0.00239	CcSEcCtD
Abacavir—Oedema—Bleomycin—lymphatic system cancer	0.000291	0.00239	CcSEcCtD
Abacavir—Infection—Bleomycin—lymphatic system cancer	0.000289	0.00238	CcSEcCtD
Abacavir—Anaemia—Carmustine—lymphatic system cancer	0.000288	0.00236	CcSEcCtD
Abacavir—Vomiting—Teniposide—lymphatic system cancer	0.000287	0.00236	CcSEcCtD
Abacavir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000285	0.00234	CcSEcCtD
Abacavir—Asthenia—Fludarabine—lymphatic system cancer	0.000285	0.00234	CcSEcCtD
Abacavir—Rash—Teniposide—lymphatic system cancer	0.000285	0.00234	CcSEcCtD
Abacavir—Dermatitis—Teniposide—lymphatic system cancer	0.000285	0.00234	CcSEcCtD
Abacavir—Headache—Teniposide—lymphatic system cancer	0.000283	0.00232	CcSEcCtD
Abacavir—Pruritus—Fludarabine—lymphatic system cancer	0.000281	0.00231	CcSEcCtD
Abacavir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000281	0.00231	CcSEcCtD
Abacavir—Leukopenia—Carmustine—lymphatic system cancer	0.000279	0.00229	CcSEcCtD
Abacavir—Anorexia—Bleomycin—lymphatic system cancer	0.000278	0.00228	CcSEcCtD
Abacavir—Anaemia—Vincristine—lymphatic system cancer	0.000275	0.00226	CcSEcCtD
Abacavir—Hypotension—Bleomycin—lymphatic system cancer	0.000272	0.00223	CcSEcCtD
Abacavir—Diarrhoea—Fludarabine—lymphatic system cancer	0.000272	0.00223	CcSEcCtD
Abacavir—Convulsion—Carmustine—lymphatic system cancer	0.00027	0.00222	CcSEcCtD
Abacavir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000269	0.00221	CcSEcCtD
Abacavir—Nausea—Teniposide—lymphatic system cancer	0.000268	0.0022	CcSEcCtD
Abacavir—Anaemia—Mitoxantrone—lymphatic system cancer	0.000268	0.0022	CcSEcCtD
Abacavir—Vertigo—Vincristine—lymphatic system cancer	0.000267	0.00219	CcSEcCtD
Abacavir—Hepatic failure—Methotrexate—lymphatic system cancer	0.000267	0.00219	CcSEcCtD
Abacavir—Leukopenia—Vincristine—lymphatic system cancer	0.000266	0.00219	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000265	0.00218	CcSEcCtD
Abacavir—Myalgia—Carmustine—lymphatic system cancer	0.000265	0.00218	CcSEcCtD
Abacavir—Anxiety—Carmustine—lymphatic system cancer	0.000264	0.00217	CcSEcCtD
Abacavir—Paraesthesia—Bleomycin—lymphatic system cancer	0.000262	0.00215	CcSEcCtD
Abacavir—Malaise—Mitoxantrone—lymphatic system cancer	0.000261	0.00214	CcSEcCtD
Abacavir—Dyspnoea—Bleomycin—lymphatic system cancer	0.00026	0.00213	CcSEcCtD
Abacavir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000259	0.00213	CcSEcCtD
Abacavir—Convulsion—Vincristine—lymphatic system cancer	0.000258	0.00212	CcSEcCtD
Abacavir—Oedema—Carmustine—lymphatic system cancer	0.000254	0.00209	CcSEcCtD
Abacavir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000253	0.00208	CcSEcCtD
Abacavir—Myalgia—Vincristine—lymphatic system cancer	0.000253	0.00208	CcSEcCtD
Abacavir—Cough—Mitoxantrone—lymphatic system cancer	0.000253	0.00207	CcSEcCtD
Abacavir—Infection—Carmustine—lymphatic system cancer	0.000253	0.00207	CcSEcCtD
Abacavir—Vomiting—Fludarabine—lymphatic system cancer	0.000253	0.00207	CcSEcCtD
Abacavir—Convulsion—Mitoxantrone—lymphatic system cancer	0.000251	0.00206	CcSEcCtD
Abacavir—Rash—Fludarabine—lymphatic system cancer	0.00025	0.00206	CcSEcCtD
Abacavir—Dermatitis—Fludarabine—lymphatic system cancer	0.00025	0.00205	CcSEcCtD
Abacavir—Pain—Bleomycin—lymphatic system cancer	0.000249	0.00204	CcSEcCtD
Abacavir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000249	0.00204	CcSEcCtD
Abacavir—Headache—Fludarabine—lymphatic system cancer	0.000249	0.00204	CcSEcCtD
Abacavir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000247	0.00202	CcSEcCtD
Abacavir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000247	0.00202	CcSEcCtD
Abacavir—Anxiety—Mitoxantrone—lymphatic system cancer	0.000246	0.00202	CcSEcCtD
Abacavir—Lethargy—Methotrexate—lymphatic system cancer	0.000244	0.00201	CcSEcCtD
Abacavir—Discomfort—Mitoxantrone—lymphatic system cancer	0.000244	0.002	CcSEcCtD
Abacavir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000243	0.00199	CcSEcCtD
Abacavir—Oedema—Vincristine—lymphatic system cancer	0.000243	0.00199	CcSEcCtD
Abacavir—Anorexia—Carmustine—lymphatic system cancer	0.000242	0.00199	CcSEcCtD
Abacavir—Infection—Vincristine—lymphatic system cancer	0.000241	0.00198	CcSEcCtD
Abacavir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00024	0.00197	CcSEcCtD
Abacavir—Nervous system disorder—Vincristine—lymphatic system cancer	0.000238	0.00195	CcSEcCtD
Abacavir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000238	0.00195	CcSEcCtD
Abacavir—Hypotension—Carmustine—lymphatic system cancer	0.000238	0.00195	CcSEcCtD
Abacavir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000236	0.00194	CcSEcCtD
Abacavir—Oedema—Mitoxantrone—lymphatic system cancer	0.000236	0.00194	CcSEcCtD
Abacavir—Nausea—Fludarabine—lymphatic system cancer	0.000236	0.00194	CcSEcCtD
Abacavir—Infection—Mitoxantrone—lymphatic system cancer	0.000235	0.00193	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000232	0.0019	CcSEcCtD
Abacavir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000231	0.0019	CcSEcCtD
Abacavir—Urticaria—Bleomycin—lymphatic system cancer	0.000231	0.0019	CcSEcCtD
Abacavir—Anorexia—Vincristine—lymphatic system cancer	0.000231	0.0019	CcSEcCtD
Abacavir—Body temperature increased—Bleomycin—lymphatic system cancer	0.00023	0.00189	CcSEcCtD
Abacavir—Insomnia—Carmustine—lymphatic system cancer	0.00023	0.00189	CcSEcCtD
Abacavir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00023	0.00188	CcSEcCtD
Abacavir—Paraesthesia—Carmustine—lymphatic system cancer	0.000228	0.00187	CcSEcCtD
Abacavir—Hypotension—Vincristine—lymphatic system cancer	0.000227	0.00186	CcSEcCtD
Abacavir—Dyspnoea—Carmustine—lymphatic system cancer	0.000227	0.00186	CcSEcCtD
Abacavir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000225	0.00185	CcSEcCtD
Abacavir—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000221	0.00182	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000221	0.00182	CcSEcCtD
Abacavir—Decreased appetite—Carmustine—lymphatic system cancer	0.000221	0.00181	CcSEcCtD
Abacavir—Hypotension—Mitoxantrone—lymphatic system cancer	0.000221	0.00181	CcSEcCtD
Abacavir—Insomnia—Vincristine—lymphatic system cancer	0.000219	0.0018	CcSEcCtD
Abacavir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000219	0.0018	CcSEcCtD
Abacavir—Paraesthesia—Vincristine—lymphatic system cancer	0.000218	0.00179	CcSEcCtD
Abacavir—Pain—Carmustine—lymphatic system cancer	0.000217	0.00178	CcSEcCtD
Abacavir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000216	0.00177	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000215	0.00177	CcSEcCtD
Abacavir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000215	0.00176	CcSEcCtD
Abacavir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000212	0.00174	CcSEcCtD
Abacavir—Decreased appetite—Vincristine—lymphatic system cancer	0.000211	0.00173	CcSEcCtD
Abacavir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000211	0.00173	CcSEcCtD
Abacavir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00021	0.00172	CcSEcCtD
Abacavir—Feeling abnormal—Carmustine—lymphatic system cancer	0.000209	0.00172	CcSEcCtD
Abacavir—Fatigue—Vincristine—lymphatic system cancer	0.000209	0.00172	CcSEcCtD
Abacavir—Asthenia—Bleomycin—lymphatic system cancer	0.000209	0.00172	CcSEcCtD
Abacavir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000208	0.00171	CcSEcCtD
Abacavir—Pain—Vincristine—lymphatic system cancer	0.000208	0.0017	CcSEcCtD
Abacavir—Pruritus—Bleomycin—lymphatic system cancer	0.000206	0.00169	CcSEcCtD
Abacavir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000205	0.00169	CcSEcCtD
Abacavir—Fatigue—Mitoxantrone—lymphatic system cancer	0.000204	0.00167	CcSEcCtD
Abacavir—Pancreatitis—Methotrexate—lymphatic system cancer	0.000203	0.00167	CcSEcCtD
Abacavir—Pain—Mitoxantrone—lymphatic system cancer	0.000202	0.00166	CcSEcCtD
Abacavir—Body temperature increased—Carmustine—lymphatic system cancer	0.000201	0.00165	CcSEcCtD
Abacavir—Abdominal pain—Carmustine—lymphatic system cancer	0.000201	0.00165	CcSEcCtD
Abacavir—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000199	0.00163	CcSEcCtD
Abacavir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000198	0.00163	CcSEcCtD
Abacavir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000195	0.0016	CcSEcCtD
Abacavir—Neutropenia—Methotrexate—lymphatic system cancer	0.000194	0.00159	CcSEcCtD
Abacavir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000193	0.00159	CcSEcCtD
Abacavir—Abdominal pain—Vincristine—lymphatic system cancer	0.000192	0.00157	CcSEcCtD
Abacavir—Body temperature increased—Vincristine—lymphatic system cancer	0.000192	0.00157	CcSEcCtD
Abacavir—Urticaria—Mitoxantrone—lymphatic system cancer	0.000188	0.00154	CcSEcCtD
Abacavir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000187	0.00154	CcSEcCtD
Abacavir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000187	0.00153	CcSEcCtD
Abacavir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000187	0.00153	CcSEcCtD
Abacavir—Pneumonia—Methotrexate—lymphatic system cancer	0.000186	0.00152	CcSEcCtD
Abacavir—Vomiting—Bleomycin—lymphatic system cancer	0.000185	0.00152	CcSEcCtD
Abacavir—Depression—Methotrexate—lymphatic system cancer	0.000184	0.00151	CcSEcCtD
Abacavir—Rash—Bleomycin—lymphatic system cancer	0.000184	0.00151	CcSEcCtD
Abacavir—Dermatitis—Bleomycin—lymphatic system cancer	0.000183	0.00151	CcSEcCtD
Abacavir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000183	0.0015	CcSEcCtD
Abacavir—Asthenia—Carmustine—lymphatic system cancer	0.000182	0.0015	CcSEcCtD
Abacavir—Renal failure—Methotrexate—lymphatic system cancer	0.000181	0.00149	CcSEcCtD
Abacavir—Stomatitis—Methotrexate—lymphatic system cancer	0.00018	0.00148	CcSEcCtD
Abacavir—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000179	0.00147	CcSEcCtD
Abacavir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000179	0.00147	CcSEcCtD
Abacavir—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000175	0.00143	CcSEcCtD
Abacavir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000174	0.00143	CcSEcCtD
Abacavir—Asthenia—Vincristine—lymphatic system cancer	0.000174	0.00143	CcSEcCtD
Abacavir—Diarrhoea—Carmustine—lymphatic system cancer	0.000174	0.00143	CcSEcCtD
Abacavir—Nausea—Bleomycin—lymphatic system cancer	0.000173	0.00142	CcSEcCtD
Abacavir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00017	0.00139	CcSEcCtD
Abacavir—Dizziness—Carmustine—lymphatic system cancer	0.000168	0.00138	CcSEcCtD
Abacavir—Diarrhoea—Vincristine—lymphatic system cancer	0.000166	0.00136	CcSEcCtD
Abacavir—Hepatitis—Methotrexate—lymphatic system cancer	0.000166	0.00136	CcSEcCtD
Abacavir—Pharyngitis—Methotrexate—lymphatic system cancer	0.000164	0.00135	CcSEcCtD
Abacavir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000162	0.00133	CcSEcCtD
Abacavir—Vomiting—Carmustine—lymphatic system cancer	0.000162	0.00133	CcSEcCtD
Abacavir—Dizziness—Vincristine—lymphatic system cancer	0.00016	0.00132	CcSEcCtD
Abacavir—Rash—Carmustine—lymphatic system cancer	0.00016	0.00132	CcSEcCtD
Abacavir—Dermatitis—Carmustine—lymphatic system cancer	0.00016	0.00131	CcSEcCtD
Abacavir—Headache—Carmustine—lymphatic system cancer	0.000159	0.00131	CcSEcCtD
Abacavir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000157	0.00129	CcSEcCtD
Abacavir—Vomiting—Vincristine—lymphatic system cancer	0.000154	0.00127	CcSEcCtD
Abacavir—Rash—Vincristine—lymphatic system cancer	0.000153	0.00126	CcSEcCtD
Abacavir—Dermatitis—Vincristine—lymphatic system cancer	0.000153	0.00126	CcSEcCtD
Abacavir—Headache—Vincristine—lymphatic system cancer	0.000152	0.00125	CcSEcCtD
Abacavir—Nausea—Carmustine—lymphatic system cancer	0.000151	0.00124	CcSEcCtD
Abacavir—Vomiting—Mitoxantrone—lymphatic system cancer	0.00015	0.00123	CcSEcCtD
Abacavir—Immune system disorder—Methotrexate—lymphatic system cancer	0.00015	0.00123	CcSEcCtD
Abacavir—Rash—Mitoxantrone—lymphatic system cancer	0.000149	0.00122	CcSEcCtD
Abacavir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000149	0.00122	CcSEcCtD
Abacavir—Chills—Methotrexate—lymphatic system cancer	0.000149	0.00122	CcSEcCtD
Abacavir—Headache—Mitoxantrone—lymphatic system cancer	0.000148	0.00122	CcSEcCtD
Abacavir—Alopecia—Methotrexate—lymphatic system cancer	0.000146	0.0012	CcSEcCtD
Abacavir—Malnutrition—Methotrexate—lymphatic system cancer	0.000144	0.00118	CcSEcCtD
Abacavir—Nausea—Vincristine—lymphatic system cancer	0.000144	0.00118	CcSEcCtD
Abacavir—Nausea—Mitoxantrone—lymphatic system cancer	0.00014	0.00115	CcSEcCtD
Abacavir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000134	0.0011	CcSEcCtD
Abacavir—Anaemia—Methotrexate—lymphatic system cancer	0.000133	0.00109	CcSEcCtD
Abacavir—Malaise—Methotrexate—lymphatic system cancer	0.00013	0.00107	CcSEcCtD
Abacavir—Vertigo—Methotrexate—lymphatic system cancer	0.00013	0.00106	CcSEcCtD
Abacavir—Leukopenia—Methotrexate—lymphatic system cancer	0.000129	0.00106	CcSEcCtD
Abacavir—Cough—Methotrexate—lymphatic system cancer	0.000126	0.00103	CcSEcCtD
Abacavir—Convulsion—Methotrexate—lymphatic system cancer	0.000125	0.00103	CcSEcCtD
Abacavir—Myalgia—Methotrexate—lymphatic system cancer	0.000123	0.00101	CcSEcCtD
Abacavir—Arthralgia—Methotrexate—lymphatic system cancer	0.000123	0.00101	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000122	0.001	CcSEcCtD
Abacavir—Discomfort—Methotrexate—lymphatic system cancer	0.000121	0.000996	CcSEcCtD
Abacavir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000118	0.000967	CcSEcCtD
Abacavir—Infection—Methotrexate—lymphatic system cancer	0.000117	0.00096	CcSEcCtD
Abacavir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000115	0.000948	CcSEcCtD
Abacavir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000115	0.000946	CcSEcCtD
Abacavir—Skin disorder—Methotrexate—lymphatic system cancer	0.000114	0.000939	CcSEcCtD
Abacavir—Anorexia—Methotrexate—lymphatic system cancer	0.000112	0.000921	CcSEcCtD
Abacavir—Hypotension—Methotrexate—lymphatic system cancer	0.00011	0.000903	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000107	0.000881	CcSEcCtD
Abacavir—Insomnia—Methotrexate—lymphatic system cancer	0.000107	0.000874	CcSEcCtD
Abacavir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000106	0.000868	CcSEcCtD
Abacavir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000105	0.000862	CcSEcCtD
Abacavir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000102	0.00084	CcSEcCtD
Abacavir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000102	0.000835	CcSEcCtD
Abacavir—Fatigue—Methotrexate—lymphatic system cancer	0.000102	0.000833	CcSEcCtD
Abacavir—Pain—Methotrexate—lymphatic system cancer	0.000101	0.000827	CcSEcCtD
Abacavir—Feeling abnormal—Methotrexate—lymphatic system cancer	9.7e-05	0.000797	CcSEcCtD
Abacavir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	9.63e-05	0.00079	CcSEcCtD
Abacavir—Urticaria—Methotrexate—lymphatic system cancer	9.35e-05	0.000768	CcSEcCtD
Abacavir—Abdominal pain—Methotrexate—lymphatic system cancer	9.31e-05	0.000764	CcSEcCtD
Abacavir—Body temperature increased—Methotrexate—lymphatic system cancer	9.31e-05	0.000764	CcSEcCtD
Abacavir—Hypersensitivity—Methotrexate—lymphatic system cancer	8.68e-05	0.000712	CcSEcCtD
Abacavir—Asthenia—Methotrexate—lymphatic system cancer	8.45e-05	0.000694	CcSEcCtD
Abacavir—Pruritus—Methotrexate—lymphatic system cancer	8.33e-05	0.000684	CcSEcCtD
Abacavir—Diarrhoea—Methotrexate—lymphatic system cancer	8.06e-05	0.000661	CcSEcCtD
Abacavir—Dizziness—Methotrexate—lymphatic system cancer	7.79e-05	0.000639	CcSEcCtD
Abacavir—Vomiting—Methotrexate—lymphatic system cancer	7.49e-05	0.000615	CcSEcCtD
Abacavir—Rash—Methotrexate—lymphatic system cancer	7.42e-05	0.00061	CcSEcCtD
Abacavir—Dermatitis—Methotrexate—lymphatic system cancer	7.42e-05	0.000609	CcSEcCtD
Abacavir—Headache—Methotrexate—lymphatic system cancer	7.38e-05	0.000606	CcSEcCtD
Abacavir—Nausea—Methotrexate—lymphatic system cancer	6.99e-05	0.000574	CcSEcCtD
